Gastrointestinal motility and disorders
Moving in Gut.
- Moved this week
- 2
Rebuilt
Latest in Gastrointestinal motility and disorders
Newest first · last 60 days
Translumbosacral neuromodulation therapy with 2400 and 3600 magnetic pulses significantly reduces fecal incontinence episodes compared to sham, with responder rates up to 81.1%.
- Open access
- 1 cites
Fusobacterium nucleatum amplifies Bacteroides fragilis-induced neuron loss and gut motility issues, with 2-hydroxybutyric acid worsening neurotoxicity in mice.
Molecular and functional organization of nutrient absorption varies regionally along the small intestine, with distinct gene expression profiles across axes.
Restoring gut barrier function with targeted therapies could transform treatment of gut-brain interaction disorders, reducing symptoms in conditions like IBS and dyspepsia.
Fecal microbiota transplantation shows potential to improve irritable bowel syndrome symptoms, with significant effects observed in some analyses but overall very low certainty evidence.
- Open access
- 1 cites
Deoxycholate promotes Clostridioides difficile virulence by stimulating Escherichia coli to produce proline, boosting infection severity by 50-fold in co-infection models.
- Open access
A single Faecalibacterium prausnitzii EXL01 strain significantly reduces recurrent Clostridioides difficile infection in humans, with 83.3% remaining recurrence-free at 8 weeks.
The global prevalence of disorders of gut-brain interaction remains consistent at around 41% using Rome V criteria, confirming high worldwide burden.
- Open access
- 2 cites
A machine learning scoring system using metabolic biomarkers achieves an AUC of 0.910 for IBD diagnosis, surpassing traditional fecal calprotectin tests.
- Open access
Targeted exclusion diets based on confocal laser endomicroscopy do not significantly improve irritable bowel syndrome symptoms, with response rates of 42% versus 36%.
- Open access
A joint consensus defines "IBD with IBS-like symptoms" and recommends standardized evaluation and treatment strategies for patients in remission with persistent gastrointestinal symptoms.
- Open access
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4